Healthcare -
Biotechnology - NASDAQ - US
$ 0.3053
0.792 %
$ 38 M
Market Cap
-0.55
P/E
MRSN - OPERATING INCOME
Operating Income MRSN - Mersana Therapeutics, Inc.
-73.3 M
LAST VALUE
40.14%
2 YEAR CAGR
-20.21%
5 YEAR CAGR
0.00%
10 YEAR CAGR